In the latest session, Sotera Health Co (NASDAQ: SHC) closed at $13.11 down -8.51% from its previous closing price of $14.33. In other words, the price has decreased by -$1.22 from its previous closing price. On the day, 2000142 shares were traded. SHC stock price reached its highest trading level at $14.47 during the session, while it also had its lowest trading level at $13.05.
Ratios:
For a deeper understanding of Sotera Health Co’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.19 and its Current Ratio is at 2.42. In the meantime, Its Debt-to-Equity ratio is 5.24 whereas as Long-Term Debt/Eq ratio is at 5.20.
On June 26, 2023, KeyBanc Capital Markets Upgraded its rating to Overweight which previously was Sector Weight but kept the price unchanged to $24.
JP Morgan Upgraded its Underweight to Neutral on January 23, 2023, whereas the target price for the stock was revised from $6 to $18.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 04 ’24 when WARBURG PINCUS & CO. sold 16,594,363 shares for $14.31 per share. The transaction valued at 237,423,849 led to the insider holds 88,822,952 shares of the business.
WARBURG PINCUS & CO. sold 16,594,363 shares of SHC for $237,423,849 on Mar 04 ’24. The Director now owns 88,822,952 shares after completing the transaction at $14.31 per share. On Mar 04 ’24, another insider, GTCR INVESTMENT XI LLC, who serves as the Director of the company, sold 11,062,908 shares for $14.31 each. As a result, the insider received 158,282,556 and left with 59,215,301 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SHC now has a Market Capitalization of 4.05B and an Enterprise Value of 6.08B. As of this moment, Sotera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 72.95, and their Forward P/E ratio for the next fiscal year is 14.86. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.08. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.53 while its Price-to-Book (P/B) ratio in mrq is 8.36. Its current Enterprise Value per Revenue stands at 5.80 whereas that against EBITDA is 14.95.
Stock Price History:
Over the past 52 weeks, SHC has reached a high of $19.40, while it has fallen to a 52-week low of $12.34. The 50-Day Moving Average of the stock is 15.23, while the 200-Day Moving Average is calculated to be 15.52.
Shares Statistics:
For the past three months, SHC has traded an average of 1.38M shares per day and 1.63M over the past ten days. A total of 282.83M shares are outstanding, with a floating share count of 126.48M. Insiders hold about 55.28% of the company’s shares, while institutions hold 28.66% stake in the company. Shares short for SHC as of Feb 29, 2024 were 12.03M with a Short Ratio of 8.73, compared to 10.96M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.25% and a Short% of Float of 12.07%.
Earnings Estimates
There are 7 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.13 for the current quarter, with a high estimate of $0.17 and a low estimate of $0.11, while EPS last year was $0.13. The consensus estimate for the next quarter is $0.19, with high estimates of $0.25 and low estimates of $0.16.
Analysts are recommending an EPS of between $0.91 and $0.7 for the fiscal current year, implying an average EPS of $0.74. EPS for the following year is $0.88, with 7 analysts recommending between $1.05 and $0.82.
Revenue Estimates
A total of 6 analysts believe the company’s revenue will be $244.93M this quarter.It ranges from a high estimate of $255M to a low estimate of $234.8M. As of the current estimate, Sotera Health Co’s year-ago sales were $220.59M, an estimated increase of 11.00% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $276.41M, an increase of 8.30% less than the figure of $11.00% in the same quarter last year. There is a high estimate of $285.81M for the next quarter, whereas the lowest estimate is $265.71M.
A total of 7 analysts have provided revenue estimates for SHC’s current fiscal year. The highest revenue estimate was $1.1B, while the lowest revenue estimate was $1.09B, resulting in an average revenue estimate of $1.1B. In the same quarter a year ago, actual revenue was $1.05B, up 4.60% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $1.18B in the next fiscal year. The high estimate is $1.19B and the low estimate is $1.17B. The average revenue growth estimate for next year is up 7.10% from the average revenue estimate for this year.
